ReviewBioprocess and biosystems engineering2022
Bioremediation of perfluorochemicals: current state and the way forward.
Review in Bioprocess and biosystems engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 38 citations in OpenAlex.
- Native and Alien Antarctic Grasses as a Habitat for Fungi.International journal of molecular sciences · 2024Article
- First Clarification of the Mechanism of Action of the Apple Glycosyltransferase MdUGT91AJ2 Involved in the Detoxification Metabolism of the Triketone Herbicide Sulcotrione.Plants (Basel, Switzerland) · 2024Article
- White Rot Fungi as Tools for the Bioremediation of Xenobiotics: A Review.Journal of fungi (Basel, Switzerland) · 2024Review
- The EU's Per- and Polyfluoroalkyl Substances (PFAS) Ban: A Case of Policy over Science.Toxics · 2023Review
- The Potential of Microbubbles as a Cancer Eradication Theranostic Agent.Pharmaceutical nanotechnology · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Perfluorochemicals are widely found in the environment due to their versatile uses and persistent nature. Perfluorochemicals have also been detected in human and animals due to direct or indirect exposures, giving rise to health concerns. This review aims to examine the bioremediation of perfluorochemicals with plants, bacteria and fungi, including their efficiency and limitations. It also aims to propose the future prospects of bioremediation of perfluorochemicals. This review retrieved peer-reviewed journal articles published between 2010 and 2021 from journal databases consisting of Web of Science, Scopus and ScienceDirect. This review shows that multiple Pseudomonas species could degrade perfluorochemicals particularly perfluoroalkyl acids under aerobic condition. Acidimicrobium sp. degraded perfluoroalkyl acids anaerobically in the presence of electron donors. A mixed Pseudomonas culture was more effective than pure cultures. Multiple plants were found to bioconcentrate perfluorochemicals and many demonstrated the ability to hyperaccumulate perfluoroalkyl acids, particularly Festuca rubra, Salix nigra and Betula nigra. Fungal species, particularly Pseudeurotium sp. and Geomyces sp., have the potential to degrade perfluorooctanoic acid or perfluorooctane sulphonic acid. Perfluorochemicals bioremediation could be advanced with identification of more candidate species for bioremediation, optimization of bioremediation conditions, mixed culturing, experiments with environmental media and studies on the biochemical pathways of biotransformation. This review provides comprehensive insight into the efficiency of different bacterial, plant and fungal species in perfluorochemicals bioremediation under different conditions, their limitations and improvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.